Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 AUG 24 ... study in Regional Anesthesia and Pain Medicine (Extended-Release Epidural Morphine (DepoDur) Following Epidural Bupivacaine in Patients Undergoing Lower Abdominal Surgery A ...
2007 AUG 27 ... care setting, announced it has acquired exclusive marketing and distribution rights to DepoDur(R) (morphine sulfate extended release liposome injection) for the Americas from San ...
2008 MAR 24 ... the management of acute myocardial infarction. Other product offerings from EKR include DepoDur(R), an injectable morphine acquired in August 2007 for the management of post operative ...
2007 NOV 5 ... sales force, and in August 2007 the product portfolio was enriched with the addition of DepoDur(R), a single epidural injection of morphine to provide up to 48 hours of pain relief ...
2007 FEB 5 ... the following developments:
Following an assessment of the status of DepoDur, the company has notified SkyePharma PLC of its intent to terminate its development and ...
2007 AUG 27 ... C financing, EKR Therapeutics also announced the acquisition of its second product, DepoDur(R), a patented morphine sulfate extended-release liposome epidural injection for ...
2007 OCT 15 ... markets, announced it has acquired exclusive marketing and distribution rights to DepoDur(R) (morphine sulphate extended release liposome injection) for Europe and a number of ...
2007 APR 9 ... the following developments:
Following an assessment of the status of DepoDur, the company has notified SkyePharma PLC of its intent to terminate its development and ...
2007 APR 3 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
2007 NOV 5 ... has been granted registration approval by the Therapeutic Goods Administration for DepoDur(R) in Australia. DepoDur, which was developed by and ...
2007 DEC 31 ... lead Pacira by enhancing the revenue opportunities of our existing commercial products, DepoDur and DepoCyt, optimizing the development and launch of our key asset, DepoBupivacaine, ...
2007 APR 9 ... note, with additional contingent payments linked to the future sales performance of DepoDur, a pain management product of SkyePharma's injectables business which has been divested ...
2007 MAY 21 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
2007 MAR 6 ... the following developments:
Following an assessment of the status of DepoDur, the company has notified SkyePharma PLC of its intent to terminate its development and ...
2007 JUL 2 ... the following developments:
Following an assessment of the status of DepoDur, the company has notified SkyePharma PLC of its intent to terminate its development and ...
2007 JAN 9 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
2007 SEP 24 ... study in Anesthesia and Analgesia (Single-dose, extended-release epidural morphine (DepoDur(TM)) compared to conventional epidural morphine for post-cesarean pain. Anesthesia and ...
2006 MAY 29 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
2006 DEC 4 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
2007 JUN 19 ... Medicines and Healthcare products Regulatory Agency (MHRA) has approved SkyePharma's DepoDur for the treatment of pain following major surgery.
Previously referred to ...
